CobaltMaghrebV1, France, Analysis, bibRecord, 000005

The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria

Identifieur interne : 000005 ( France/Analysis ); précédent : 000004; suivant : 000006

The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria

Auteurs : Xian-Zhi Li [Canada] ; Patrick Plésiat [France] ; Hiroshi Nikaido [États-Unis]

Source :

Clinical Microbiology Reviews [ 0893-8512 ] ; 2015.

RBID : PMC:4402952

Abstract

SUMMARY

The global emergence of multidrug-resistant Gram-negative bacteria is a growing threat to antibiotic therapy. The chromosomally encoded drug efflux mechanisms that are ubiquitous in these bacteria greatly contribute to antibiotic resistance and present a major challenge for antibiotic development. Multidrug pumps, particularly those represented by the clinically relevant AcrAB-TolC and Mex pumps of the resistance-nodulation-division (RND) superfamily, not only mediate intrinsic and acquired multidrug resistance (MDR) but also are involved in other functions, including the bacterial stress response and pathogenicity. Additionally, efflux pumps interact synergistically with other resistance mechanisms (e.g., with the outer membrane permeability barrier) to increase resistance levels. Since the discovery of RND pumps in the early 1990s, remarkable scientific and technological advances have allowed for an in-depth understanding of the structural and biochemical basis, substrate profiles, molecular regulation, and inhibition of MDR pumps. However, the development of clinically useful efflux pump inhibitors and/or new antibiotics that can bypass pump effects continues to be a challenge. Plasmid-borne efflux pump genes (including those for RND pumps) have increasingly been identified. This article highlights the recent progress obtained for organisms of clinical significance, together with methodological considerations for the characterization of MDR pumps.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402952

DOI: 10.1128/CMR.00117-14
PubMed: 25788514
PubMed Central: 4402952

Affiliations:

Links to Exploration step

PMC:4402952

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria</title>
<author><name sortKey="Li, Xian Zhi" sort="Li, Xian Zhi" uniqKey="Li X" first="Xian-Zhi" last="Li">Xian-Zhi Li</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Human Safety Division, Veterinary Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Human Safety Division, Veterinary Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Plesiat, Patrick" sort="Plesiat, Patrick" uniqKey="Plesiat P" first="Patrick" last="Plésiat">Patrick Plésiat</name>
<affiliation wicri:level="3"><nlm:aff id="aff2">Laboratoire de Bactériologie, Faculté de Médecine-Pharmacie, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Bactériologie, Faculté de Médecine-Pharmacie, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon</wicri:regionArea>
<placeName><region type="region">Bourgogne-Franche-Comté</region>
<region type="old region">Franche-Comté</region>
<settlement type="city">Besançon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nikaido, Hiroshi" sort="Nikaido, Hiroshi" uniqKey="Nikaido H" first="Hiroshi" last="Nikaido">Hiroshi Nikaido</name>
<affiliation wicri:level="2"><nlm:aff id="aff3">Department of Molecular and Cell Biology, University of California, Berkeley, California, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular and Cell Biology, University of California, Berkeley, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">25788514</idno>
<idno type="pmc">4402952</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402952</idno>
<idno type="RBID">PMC:4402952</idno>
<idno type="doi">10.1128/CMR.00117-14</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">000484</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000484</idno>
<idno type="wicri:Area/Pmc/Curation">000483</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000483</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000054</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000054</idno>
<idno type="wicri:Area/Ncbi/Merge">000374</idno>
<idno type="wicri:Area/Ncbi/Curation">000374</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000374</idno>
<idno type="wicri:doubleKey">0893-8512:2015:Li X:the:challenge:of</idno>
<idno type="wicri:Area/Main/Merge">000060</idno>
<idno type="wicri:Area/Main/Curation">000060</idno>
<idno type="wicri:Area/Main/Exploration">000060</idno>
<idno type="wicri:Area/France/Extraction">000005</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria</title>
<author><name sortKey="Li, Xian Zhi" sort="Li, Xian Zhi" uniqKey="Li X" first="Xian-Zhi" last="Li">Xian-Zhi Li</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Human Safety Division, Veterinary Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Human Safety Division, Veterinary Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Plesiat, Patrick" sort="Plesiat, Patrick" uniqKey="Plesiat P" first="Patrick" last="Plésiat">Patrick Plésiat</name>
<affiliation wicri:level="3"><nlm:aff id="aff2">Laboratoire de Bactériologie, Faculté de Médecine-Pharmacie, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Bactériologie, Faculté de Médecine-Pharmacie, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon</wicri:regionArea>
<placeName><region type="region">Bourgogne-Franche-Comté</region>
<region type="old region">Franche-Comté</region>
<settlement type="city">Besançon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nikaido, Hiroshi" sort="Nikaido, Hiroshi" uniqKey="Nikaido H" first="Hiroshi" last="Nikaido">Hiroshi Nikaido</name>
<affiliation wicri:level="2"><nlm:aff id="aff3">Department of Molecular and Cell Biology, University of California, Berkeley, California, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular and Cell Biology, University of California, Berkeley, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Clinical Microbiology Reviews</title>
<idno type="ISSN">0893-8512</idno>
<idno type="eISSN">1098-6618</idno>
<imprint><date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><title>SUMMARY</title>
<p>The global emergence of multidrug-resistant Gram-negative bacteria is a growing threat to antibiotic therapy. The chromosomally encoded drug efflux mechanisms that are ubiquitous in these bacteria greatly contribute to antibiotic resistance and present a major challenge for antibiotic development. Multidrug pumps, particularly those represented by the clinically relevant AcrAB-TolC and Mex pumps of the resistance-nodulation-division (RND) superfamily, not only mediate intrinsic and acquired multidrug resistance (MDR) but also are involved in other functions, including the bacterial stress response and pathogenicity. Additionally, efflux pumps interact synergistically with other resistance mechanisms (e.g., with the outer membrane permeability barrier) to increase resistance levels. Since the discovery of RND pumps in the early 1990s, remarkable scientific and technological advances have allowed for an in-depth understanding of the structural and biochemical basis, substrate profiles, molecular regulation, and inhibition of MDR pumps. However, the development of clinically useful efflux pump inhibitors and/or new antibiotics that can bypass pump effects continues to be a challenge. Plasmid-borne efflux pump genes (including those for RND pumps) have increasingly been identified. This article highlights the recent progress obtained for organisms of clinical significance, together with methodological considerations for the characterization of MDR pumps.</p>
</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region><li>Bourgogne-Franche-Comté</li>
<li>Californie</li>
<li>Franche-Comté</li>
</region>
<settlement><li>Besançon</li>
</settlement>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Li, Xian Zhi" sort="Li, Xian Zhi" uniqKey="Li X" first="Xian-Zhi" last="Li">Xian-Zhi Li</name>
</noRegion>
</country>
<country name="France"><region name="Bourgogne-Franche-Comté"><name sortKey="Plesiat, Patrick" sort="Plesiat, Patrick" uniqKey="Plesiat P" first="Patrick" last="Plésiat">Patrick Plésiat</name>
</region>
</country>
<country name="États-Unis"><region name="Californie"><name sortKey="Nikaido, Hiroshi" sort="Nikaido, Hiroshi" uniqKey="Nikaido H" first="Hiroshi" last="Nikaido">Hiroshi Nikaido</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/France/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000005 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000005 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    CobaltMaghrebV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     PMC:4402952
   |texte=   The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:25788514" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a CobaltMaghrebV1

This area was generated with Dilib version V0.6.32.
Data generation: Tue Nov 14 12:56:51 2017. Site generation: Mon Feb 12 07:59:49 2024

Serveur d'exploration sur le cobalt au Maghreb

The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria

The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le cobalt au Maghreb
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.